FIELD: medicine.
SUBSTANCE: human melanoma cell line mel Kor-TurboRFP possess the stable cultural and morphological characteristics. The cell line is characterised by the expression of melanoma (differentiation) markers -CD63, HMB45, MelanA, Tyrozinase, the absence of class one and two histocompatibility antigens. The cell line is characterised by the expression of red fluorescent protein TurboRFP. The survivor tumour cell count is evaluated after the effect of anti-cancer preparations by measuring the intrinsic fluorescence intensity of the cells mel Kor-TurboRFP in microplate wells.
EFFECT: invention provides higher efficacy and reliability of investigations of anti-cancer preparations.
2 cl, 9 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| FLUORESCENT GLIOMA CELL LINE AND METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2699754C1 |
| STABLE CELL LINE OF HUMAN OVARIAN ADENOCARCINOMA SKOV-kat | 2008 |
|
RU2404244C2 |
| APPLICATION OF HUMAN SKIN MELANOMA CELL LINE mel Cher AS POSITIVE MODEL OF VASCULOGENIC MIMICRY | 2009 |
|
RU2404243C1 |
| LINE OF CELLS OF HUMAN MELANOMA KG, SECRETING RECOMBINANT GRANULOCYTIC MACROFAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2362805C1 |
| HUMAN MELANOMA CELLULAR LINE mel Kor USED IN PREPARING ANTITUMOR VACCINE | 2005 |
|
RU2287578C1 |
| METHOD FOR INCREASING IMMUNOGENICITY OF WHOLE-CELL ANTI-CANCER VACCINE | 2010 |
|
RU2458120C1 |
| CELL PRODUCT FOR LOADING AND ACTIVATION OF HUMAN DENDRITE CELLS | 2019 |
|
RU2714208C1 |
| HUMAN SKIN MELANOMA CELL LINE mel-Alx-LP | 2022 |
|
RU2796357C1 |
| APPLICATION OF PROTEIN EXTRACT AS ANTIPROLIFERATIVE AND CYTOTOXIC AGENT | 2017 |
|
RU2671632C1 |
| STABLE HUMAN BREAST CANCER CARCINOMA CELL LINE SKBR-KAT | 2018 |
|
RU2709675C1 |
